Integra LifeSciences Announces Participation in Upcoming Investor Conferences
23 août 2022 12h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in...
Integra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO
16 août 2022 08h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that Dr. Richard Caruso,...
Integra LifeSciences Reports Second Quarter 2022 Financial Results
27 juil. 2022 06h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences Appoints Renee Lo as Director
19 juil. 2022 08h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Renee Lo...
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
01 juil. 2022 16h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- )Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial...
Integra LifeSciences Reports First Quarter 2022 Financial Results
27 avr. 2022 06h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022
01 avr. 2022 08h08 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial...
Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix
22 mars 2022 08h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company and pioneers in nerve repair, today announced...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance
23 févr. 2022 06h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
11 janv. 2022 16h30 HE
|
Integra LifeSciences Holdings Corporation
Fourth quarter 2021 revenue is expected to be in a range of $404 million to $406 million, representing an increase of approximately 4% on a reported basis and an increase of approximately 8% on an...